Back

Validation of the MIDA mortality risk score in a surgical cohort of patients with primary mitral regurgitation.

1 September 2024 (12:00 - 12:30)
Organised by: Logo
Congress Presentation Part of: Challenging decisions in valvular heart surgery Mitral Valve Regurgitation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Patrick O'Neill Gonzalez

HOSPITAL CIMA, Hermosillo Sonora (Mexico)

3 More presentations in this session

Presentation thumbnail
Mitral valve reoperation versus first-time surgery for mitral regurgitation: comparison of patient characteristics, type of surgery and mortality in a nationwide cohort
Ms S. Truong (Copenhagen University Hospital, DK)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes and impact of mitral valve surgery in atrial functional mitral regurgitation: the REVEAL-AFMR registry
Associate Professor N. Kagiyama (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Evolution and prognostic relevance of right ventricular morphofunctional parameters in patients undergoing isolated tricuspid valve surgery
Doctor M. Luque (Santiago, CL)
Abstract Slides Video

Access the full session

Session thumbnail
Challenging decisions in valvular heart surgery

The Event

Event poster

ESC Congress 2024

1 September 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
A novel echocardiographic risk score for mortality in primary mitral regurgitation surgery
thumbnail
Congress Session
Registries on valvular heart disease
thumbnail
Congress Presentation
Prediction of mortality and heart failure admission with the mitraScore after percutaneous mitral valve repair: an external validation study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources